wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34630494-6B9577EB-3BBD-4A8D-A4C0-0AE3D6AB6D90
Q34630494-6B9577EB-3BBD-4A8D-A4C0-0AE3D6AB6D90
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34630494-6B9577EB-3BBD-4A8D-A4C0-0AE3D6AB6D90
Compared benefit of approved and experimental immunosuppressive therapeutic approaches in multiple sclerosis.
P2860
Q34630494-6B9577EB-3BBD-4A8D-A4C0-0AE3D6AB6D90
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34630494-6B9577EB-3BBD-4A8D-A4C0-0AE3D6AB6D90
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2d6c1930d3f089d673731279c3405ee2cdef08b9
P2860
High-dose cyclophosphamide for moderate to severe refractory multiple sclerosis